|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Genomic and genetic alterations influence the progression of gastric cancer显示文摘Gastric cancer is one of the leading causes of cancerrelated deaths worldwide, although the incidence has gradually decreased in many Western countries. Two main gastric cancer histotypes, intestinal and diffuse, are recognised. Although most of the described genetic alterations have been observed in both types, different genetic pathways have been hypothesized. Genetic and epigenetic events, including 1q loss of heterozygosity (LOH), microsatellite instability and hypermethylation, have mostly been reported in intestinal-type gastric carcinoma and its precursor lesions, whereas 17p LOH, mutation or loss of E-cadherin are more often implicated in the development of diffuse-type gastric cancer.In this review, we summarize the sometimes contradictory findings regarding those markers which influence the progression of gastric adenocarcinoma. | Stefania Nobili Lorenzo Bruno Ida Landini Cristina Napoli Paolo Bechi Francesco Tonelli Carlos A Rubio Enrico Mini Gabriella Nesi | 2011 | World Journal of Gastroenterology2011，17，3： | 17 |
| 2 | Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers显示文摘 | Maria Morganti Monica Ciantelli Beatrice Giglioni Anna L. Putignano Stefania Nobili Laura Papi Ida Landini Cristina Napoli Rosa Valanzano Fabio Cianchi Vieri Boddi Francesco Tonelli Camillo Cortesini Teresita Mazzei Maurizio Genuardi Enrico Mini | 2005 | European Journal of Cancer2005，，14： | 1 |
| 3 | Raltitrexed (Tomudex ? ) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1)显示文摘 | Ivan Popov Alfredo Carrato Alberto Sobrero Mark Vincent David Kerr Roberto Labianca Angelo Raffaele Bianco Mostafa El-Serafi Laurent Bedenne Bernard Paillot Enrico Mini Evaristo Sanches John Welch Laurence Collette Michel Praet Jacques Wils | 2008 | European Journal of Cancer2008，，15： | 1 |
| 4 | Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies显示文摘 | Francesco Crea Stefania Nobili Elisa Paolicchi Gabriele Perrone Cristina Napoli Ida Landini Romano Danesi Enrico Mini | 2011 | Drug Resistance Updates2011，，6： | 1 |
| 5 | “Pharmacogenetics of Cancer”-Cancer Drug Resistance special issue显示文摘Pharmacogenetics and pharmacogenomics have expanded rapidly over the past years and represent one of the bases of precision medicine.The application of pharmacogenetic and pharmacogenomic approaches and tools for the selection of medications and their dosage to improve patient care is nowadays substantially increased[1,2].Prescription drug information sheets in several therapeutic areas(psychiatric,cardiovascular,analgesic,antiviral,and anticancer drugs)provide current information on pharmacogenetic and pharmacogenomic biomarkers for over 200 medicines including mandatory or recommended biomarker testing prior to initiating therapy[3]. | Enrico Mini Stefania Nobili | 2020 | Cancer Drug Resistance2020，3，2： | 0 |
| 6 | 雨天里的彩色心情显示文摘雨季里的雨水是毫不吝啬的,下起雨来,世界就像被蒙上了一层淡淡的灰,没有了绚丽的颜色,步伐急促的行人、被雨水打落的枝叶、闪烁着的红色车灯,这种天气似乎让心情也失去了色彩,变得不再美丽。 | TRANS Mini Labo Eszter Imre Enrico Zanolla Natalia Wieteska Patricia Urquiola Nadadora Kairi Eguchi&Enya Hou Paolo Cappello&Ercole Moretti Studio Katra July Adrichem 李薇 范嘉苑 | 2015 | 现代装饰(家居)2015，0，8： | 0 |
| 7 | Liquid biopsy in colorectal cancer:No longer young,but not yet old显示文摘Colorectal cancer(CRC)is one of the most prevalent cancers and the second leading cause of cancer-related deaths worldwide.The treatment strategy employed in CRC patients is becoming highly dependent on molecular characteristics present at diagnosis and during treatment.Liquid biopsy is an emerging field in the management of this cancer,and its relevance as a potential diagnostic,prognostic,monitoring,and therapeutic tool makes it a viable strategy in the clinical management of CRC patients.Liquid biopsy also has certain limitations,but these limitations seem to be at the reach of near-future technological development.In this letter,we focus on the clinical perspectives of liquid biopsy in CRC with particular regard to the various biomarkers recently identified that have been shown to be potentially useful in multiple aspects of early stage or metastatic CRC. | Giandomenico Roviello Daniele Lavacchi Lorenzo Antonuzzo Martina Catalano Enrico Mini | 2022 | World Journal of Gastroenterology2022，28，15： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员